NORDERSTEDT, Germany & LANGENHAGEN, Germany--(BUSINESS WIRE)--Sysmex Europe GmbH and AdnaGen AG announced today that they have entered into a non-exclusive European distribution agreement for all current and future AdnaGen proprietary CE-certified diagnostics as well as their research use only (RUO) products. The tests are based on the capture of circulating tumor cells (CTCs) from blood and subsequent detection and profiling of tumor markers.
